Home › Social Anxiety Disorder › NCT04663724
Computer - Based Treatment for Social Anxiety Disorder
Recruiting
Computer-Based Treatment for Social Anxiety Disorder, A Randomized Controlled Trial
Who can join
Ages 18 to 60 · All sexes
Full eligibility criteria
Inclusion Criteria: * Males and females between the ages of 18 to 60 * Current primary diagnosis of SAD * Score of at least 50 on the Liebowitz Social Anxiety Scale (self-rated version) * Fluent in English * Willing and able to give informed written consent * Ability to participate responsibly in the protocol * Normal or corrected-to-normal vision Exclusion Criteria: * Present or past psychotic episode, psychotic disorder, schizophrenia, schizoaffective disorder, or bipolar disorder * Current severe depression * Suicidal ideation or behavior * Current diagnosis of post-traumatic stress disorder, obsessive-compulsive disorder, bipolar disorder, manic episode or tic disorder * Current or past organic mental disorder, seizure disorder, epilepsy or brain injury * Current unstable or untreated medical illness * Severe alcohol use disorder, severe cannabis use disorder, and any severity of other substance use disorder (except nicotine use disorders) * Use of psychiatric medication in the past month other than a stable dose of selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), buspirone, or zolpidem for sleep for at least 3 months * Any concurrent cognitive behavioral therapy or other psychotherapy that was initiated in the past 3 months * Contraindication to MRI scanning
About the study
The present study is a controlled trial that seeks to examine the feasibility, acceptability, mechanism, and efficacy of a recently developed computer-based therapy in individuals with social anxiety disorder (SAD)
What is being tested
- Computer-Based Treatment (behavioral)
Sponsor: New York State Psychiatric Institute · Participants: 80 · Started: Feb 15, 2021
Contact the study team
- Franklin Schneier, MD · Phone: 6467748041
Official record on ClinicalTrials.gov — NCT04663724
Locations in the U.S.
| New York | 1051 Riverside Drive, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.